RUDN is developing partnerships with Medis pharmaceutical company (Tunisia)

RUDN CCU strengthens international cooperation with foreign companies. The successful experience of the “full cycle” from pharmaceutical development to the commercialization of the finished medicinal product with Medis has become a platform for new ideas and plans of partner organizations.

The interest of the Tunisian company was evoked by the ongoing projects of RUDN in the field of personalized medicine and the possibility of conducting research on bioequivalence based on the CCU and clinical trials of oncological drugs based on the project partners’ sites (Moscow Herzen Research Oncological Institute).

The CCU can in the future serve as a platform for the implementation of the “industrial” PhD program, having a modern instrumentation park and a training

and production site with a license to produce drugs: the company sends its employee to graduate school, after graduation the employee returns and implements the results of his or her research in production. At the moment, agreements have been reached on the exchange of scientific knowledge in the field of X-ray diffraction analysis, NMR spectroscopy, melt extrusion, and metabolomics in online consultation mode and in the framework of further education programs.